Treatment of ocular disease
AssigneeAerpio Therapeutics Inc.
InventorsKevin Peters, Robert Shalwitz
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.
Claims11
A method for reducing retinal neovascularization in a human in need thereof, the method comprising administering to the human a therapeutically-effective amount of an intact monoclonal antibody, wherein the intact monoclonal antibody is R15E6 or a humanized form thereof, wherein the human has diabetic macular edema, wherein the antibody R15E6 is produced by a hybridoma deposited under the accession number ATCC PTA-7580.
Dependencies are inferred from the claim text.